Skip to main content
Vilcek Foundation
  • About
    • About

      The Vilcek Foundation raises awareness of immigrant contributions in the United States and fosters appreciation of the arts and sciences.

    • Our Mission
    • Our Founders
    • Our Team
    • Press Center
    • Contact
  • Prizes
    • Prizes

      The Vilcek Foundation Prizes celebrate extraordinary achievements in the arts and sciences.

    • About the Prizes
    • Prize Recipients
    • Vilcek Prizes

      Awards immigrants with a legacy of major accomplishments.

    • Vilcek Prizes for Creative Promise

      Recognizes young immigrant professionals for outstanding achievements.

    • Vilcek Prize for Excellence

      Celebrating intellectual and cultural leaders in the United States.

    • Marica Vilcek Prize in Art History

      Honors art historians, curators, and fine arts professionals.

  • Art
  • Grants
    • Grants

      Grants awarded to 501(c)(3) cultural, educational, and philanthropic organizations in the United States.

    • Grants

      Learn more and apply for a grant.

    • Grants History

      Explore a list of past Vilcek Foundation grantees.

  • Events
  • News
Sign Up Search
Home > News > Mohamed Abou Donia: “How our microbial partners affect our health.”

Mohamed Abou Donia: “How our microbial partners affect our health.”

News | March 8, 2021
Tags
biochemistry biomedical science egypt metabolism microbes microbiome Princeton University symbiosis university of utah
Share this page
Share this page on X Share this page on Facebook Share this page on LinkedIn

Mohamed Abou Donia framed by an archway of one of the Princeton University buildings.

Mohamed Abou Donia is the recipient of a 2021 Vilcek Prize for Creative Promise in Biomedical Science. He receives the award for his research leadership on the impact of the microbiome of humans and other organisms on host health, disease and ecology.

Born in Ismailia, Egypt, Mohamed first came to the United States to pursue a summer research internship. At the time of his internship, Mohamed was completing pharmacy studies in Egypt at Suez Canal University. “Once I returned to Egypt,” he said, “I knew that I wanted to come back again. I was so fascinated by the enormous diversity in the sciences that are researched in the United States… and the available directions that people can take in those explorations.”

Following pharmacy school, Mohamed was accepted into a PhD program in the United States. He recounts experiencing challenges at that time due to increased scrutiny he faced as a Muslim man living in the U.S. in the early years after 9/11. “I was fortunate to be always within diverse scientific communities that really appreciate international scholars and welcome them in a way that does not alienate us,” says Mohamed. “I am Muslim, Arab, Egyptian, and soon to be an American citizen.”

Mohamed Abou Donia and a colleague test a sample in the lab.

Mohamed’s decision to pursue research in the human microbiome grew out of his studies in pharmacy. He is fascinated by the ways small-molecule drugs interact with receptors in the human body to achieve a desired treatment outcome. “Microbes that live on humans are also capable of producing molecules of that same sort,” he says. “It’s very important to understand what these molecules do to us, and whether we can harness this repertoire of molecules for treating human diseases.”

Mohamed Abou Donia stands in front of a snow-covered Princeton University building.

Now an associate professor and a principal investigator at Princeton University, Mohamed speaks about the parallels between his research and population dynamics at large. “We, as human beings, live among each other. We interact with people from diverse backgrounds. But we also interact with plants, animals, and microbes on a daily basis.” The Donia Lab studies the interactions between humans or other host organisms – including sea slugs, algae and marine sponges – and their microbiomes. “By studying these different types of systems, we will learn really fundamental principles on how microbes can interact with their hosts and how they can affect their health and disease states,” he says.

Mohamed Abou Donia testing a sample in his lab at Princeton University.

Microbiome-organism interactions are enriched by diversity. This diversity directly impacts the health and wellness of organisms and their communities. Mohamed is similarly enthusiastic about the way diversity in the sciences and in his laboratory impacts research outcomes: “I really value the ability to incorporate scientists—as well as research—from different backgrounds,” says Mohamed. “This not only helps us to interact better among each other and to learn about each other’s cultures, but it actually directly affects the science.”

Tags
biochemistry biomedical science egypt metabolism microbes microbiome Princeton University symbiosis university of utah
Share this page
Share this page on X Share this page on Facebook Share this page on LinkedIn

Related News

November 3, 2021

Worlds Inside: Manga Explores the Work of Biochemist Mohamed Abou Donia

The second in our manga series honoring Vilcek Foundation Prizewinners, developed in partnership with Hiroki Otsuka.
February 3, 2025

Vilcek Foundation Awards $250,000 to Immigrants in Biomedical Science

Meet the recipients of the 2025 Vilcek Foundation Prizes in Biomedical Science: Marianne Bronner, Elham Azizi, Guosong Hong, and Maayan Levy.
Four diagonal splices featuring portraits of Marianne Bronner, Elham Azizi, Guosong Hong, and Maayan Levy, against a red background.
February 3, 2025

Maayan Levy: Pioneering Metabotherapy

Maayan Levy explores metabolite research across conditions such as cancer, inflammatory diseases, and post-acute infection syndromes, while championing better conditions for young mothers in academia.
Maayan smiling with her arms folded and leaning against the door frame in her office.

You may also be interested in

Mohamed Abou Donia

Mohamed Abou Donia receives the Vilcek Prize for Creative Promise in Biomedical Science for demonstrating the potential of the human microbiome as a source of novel drugs and uncovering the basis of microbiome-driven drug metabolism.
Portrait of Mohamed Abou Donia

Maayan Levy

Maayan Levy receives the Vilcek Prize for Creative Promise in Biomedical Science for her interdisciplinary approach to developing metabotherapy, engaging the potential therapeutic applications of metabolites as vehicles and targets to prevent and treat disease, including cancer.
A portrait of Maayan Levy.

Martin Jonikas

Martin Jonikas receives the Vilcek Prize for Creative Promise in Biomedical Science for molecular studies on Chlamydomonas, a model photosynthetic organism, with long-term implications for improving food-crop yield and combating climate change.
Portrait of Martin Jonikas

Join our mailing list

Sign Up
Vilcek Foundation
21 East 70th Street
New York, New York 10021

Phone: 212.472.2500

Email: info@vilcek.org

  • About
    • Our Mission
    • Our Founders
    • Our Team
    • Press Center
    • Contact
  • Prizes
    • Prize Recipients
    • Vilcek Prizes
    • Vilcek Prizes for Creative Promise
    • Vilcek Prize for Excellence
    • Marica Vilcek Prize in Art History
  • Art
  • Grants
    • Grants History
  • Events
  • News
  • Careers
Connect with us
  • Connect with the Vilcek Foundation on Facebook
  • Connect with the Vilcek Foundation on Instagram
  • Connect with the Vilcek Foundation on X
  • Connect with the Vilcek Foundation on LinkedIn
  • Connect with the Vilcek Foundation on Youtube
  • Connect with the Vilcek Foundation on Vimeo
  • Privacy Policy
  • Accessibility Statement
© 2025   Vilcek Foundation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok